Infliximab for the treatment of ankylosing spondylitis.

about

Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis.Management of ankylosing spondylitis with infliximab.

P2860

Q36773202-803732AD-DC84-4D29-A363-55A1CF89F882 Q38993236-DA5AB37A-B1BE-4406-BECE-231A9B112A6F

P2860

Infliximab for the treatment of ankylosing spondylitis.

Item

http://www.wikidata.org/entity/Q36210882

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Infliximab for the treatment of ankylosing spondylitis.

@ast

Infliximab for the treatment of ankylosing spondylitis.

@en

type

Item

label

Infliximab for the treatment of ankylosing spondylitis.

@ast

Infliximab for the treatment of ankylosing spondylitis.

@en

prefLabel

Infliximab for the treatment of ankylosing spondylitis.

@ast

Infliximab for the treatment of ankylosing spondylitis.

@en

P1476

Infliximab for the treatment of ankylosing spondylitis.

@en

P2093

Rudwaleit M

http://www.w3.org/2001/XMLSchema#string

Sieper J

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromsø, northern Norway

Six months open label trial of leflunomide in active ankylosing spondylitis

Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety

Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study

Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches

Q24816951

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.

P304

1095-1109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.5.8.1095

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16050786

http://www.w3.org/2001/XMLSchema#string

Infliximab for the treatment of ankylosing spondylitis.

about

P2860

P2860

Infliximab for the treatment of ankylosing spondylitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698